GlassScriptPhysician profile
Kathryn E Slane
NPI 1659733913
$1,986.71
in general payments reported to CMS, 2019-2025
13 companies · $243 in 2025
The $243 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $822 · 2023: $485 · 2024: $436 · 2025: $243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,164.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $390.00 | 2022 | |
| Gilead Sciences, INC. | $345.43 | 2023-2025 | Trodelvy |
| Bayer Healthcare Pharmaceuticals INC. | $257.33 | 2023 | |
| Adaptive Biotechnologies Corporation | $169.15 | 2022-2023 | Clonoseq |
| Celgene Corporation | $139.71 | 2024-2025 | Breyanzi |
| Eisai INC. | $123.59 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $122.09 | 2023-2025 | Tagrisso, Imfinzi |
| Tempus Ai, INC | $118.27 | 2024 | |
| Amgen INC. | $99.00 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $61.39 | 2023 | Tazverik |
| Coherus Oncology, INC. | $59.33 | 2022 | |
| Pharmacosmos Therapeutics INC. | $52.24 | 2023 | Monoferric |
| Daiichi Sankyo INC. | $49.18 | 2024 | Enhertu |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Slane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.